Raison Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 1.00 M
as on 10-12-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.46 Cr
as on 10-12-2024
- Revenue %
(FY 2021)
- Ebitda
- Net Worth
- Total Assets %
(FY 2021)
About Raison Bio-Tech
The Corporate was formerly known as Raison Casting Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.46 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jitendra Raiyani, Shamjibhai Raiyani, Vishal Raiyani, and One other member serve as directors at the Company.
- CIN/LLPIN
U27310GJ2006PTC048496
- Company No.
048496
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Raison Bio-Tech?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vishal Raiyani | Director | 16-Jun-2006 | Current |
Jitendra Raiyani | Director | 16-Jun-2006 | Current |
Shamjibhai Raiyani | Director | 16-Jun-2006 | Current |
Jigneshkumar Raiyani | Director | 15-Apr-2009 | Current |
Financial Performance of Raison Bio-Tech.
Raison Bio-Tech Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Raison Bio-Tech?
In 2020, Raison Bio-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Redren Energy Private LimitedActive 17 years 11 months
Jitendra Raiyani and Jigneshkumar Raiyani are mutual person
- Redeco Fibers Private LimitedActive 4 years 1 month
Jitendra Raiyani and Shamjibhai Raiyani are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Axis Bank Limited Creation Date: 04 Dec 2010 | ₹8.10 M | Satisfied |
Bank Of Baroda Creation Date: 28 Aug 2009 | ₹6.50 M | Satisfied |
How Many Employees Work at Raison Bio-Tech?
Unlock and access historical data on people associated with Raison Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raison Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raison Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.